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Introduction
Dry-eye, or keratoconjunctivitis sicca (KCS), is a relatively
common ocular condition in dogs, characterized by dry ocular
surface with corneal and conjunctival inflammation, which re-
sulted from a deficiency of tear production (Sansom and Bar-
nett, 1985; Rosa et al., 2012; Giuliano, 2013; Best et al., 2014;
Dodi, 2015). Tear film provides avascular cornea with oxygen
and nutrients, protective antibodies, antimicrobial proteins
and removes surface debris and infectious agents (Sanchez,
2007; Giuliano, 2013). Hence, lack of tear production can pre-
dispose to corneal dryness and secondary bacterial conjunc-
tivitis (Maggs et al., 2013; Best et al., 2014). 
The most common cause of KCS is immune-mediated in-
flammation of the lacrimal glands (Williams, 2008; Dodi, 2015),
there are also, other several causes, which include, congenital
abnormalities (Westermeyer et al., 2009; Hartley al., 2012), in-
fectious diseases, as canine distemper (de Almeida et al.,
2009), or leishmania (Ciaramella et al., 1997), metabolic disor-
ders (Williams et al., 2007), neurogenic, damage to parasym-
pathetic innervations (Matheis al., 2012), some drugs such as,
sulfonamide antibiotics (Collins et al., 1986) and etodolac
(Klauss et al., 2007), iatrogenic, i.e., as a result of other ocular
diseases (Helper al., 1996) and idiopathic (Matheis et al., 2012).
In early stages, the animals manifest the following clinical
signs, conjunctival hyperemia, and thick, sticky yellow to
greenish discharge that covering the cornea and accumulating
in the conjunctival sac and periocular tissue, whereas, in severe
cases, corneal opacity, pigmentation and/or corneal ulcer scan
be also developed (Sansom and Barnett, 1985; Sanchez, 2007;
Giuliano, 2013).
There are several treatments of canine dry eye include
medical therapy (topical medications), surgical treatment and
temporary punctal occlusion. Although these approaches are
technically different, they aimed essentially to provide con-
stant lubrication and conservation of existing tear (Liu and
Sadhan, 2002).
Topical medications including, artificial tear solutions, gels,
ointments and tear production stimulants is not often a help-
ful treatment of dry-eye in dogs, as the application of these
medications to the eye is challenging in affected dogs and
treatments will be required for the life of the animal (Best et
al., 2014). In addition, unresponsive cases to pharmacological
treatment have a poor prognosis, as they can develop chronic
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Surgical Versus non Surgical Techniques for Punctal Occlusion as
Alternative Methods for Treatment of Dry-eye in Dogs
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The aim of the study was to describe three alternative methods for treatment of dry-eye in dogs and
to determine the most appropriate method for clinical application. These treatments were include, sur-
gical punctal occlusion and non-surgical temporary occlusion using silicon plugs and butyl-cyanoacry-
late adhesive solution. It was carried out in two stages, stage I: to evaluate the efficacy of the three
techniques in 12 normal dogs, which allocated into three equal groups as follows, silicon plugs (G1),
butyl-cyanoacrlate adhesive (G2) and surgical punctal occlusion (G3). Stage II: a clinical study in nine
clinical cases affected with dry-eye. The upper and lower puncta were obstructed, and Schirmer tear
test I (STTI) values and Jones test were performed before and after carrying out the occlusion technique.
Each technique was evaluated twice weekly for 60 days (stage I) and 30 days (stage II). All techniques
improved the results of STTI values comparing to their control groups, with persistency period 20-23
days (G1), 12-16 days (G2) and 60 days (G3). The study proved that surgical occlusion was highly suc-
cessful as permanent method with minimal complications and would be the treatment of choice for
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keratitis, which lead to permanent corneal fibrosis, ulceration,
pigmentation and consequently, can lead to vision loss (San-
som and Barnett, 1985). For these unresponsive cases, alter-
native treatments are considered, such as, parotid duct
transposition (PDT) (Rhodes et al., 2012); labial salivary gland
autograft (Castanho et al., 2013) and non surgical (temporary)
punctal occlusion using silicon plugs (Williams, 2002; Gelatt et
al., 2006) or other adhesives (Rosa et al., 2012; Honsho et al.,
2014).
Parotid duct transposition (PDT) is successful in treatment
of dry eye; however, it has a high complication rate (Rhodes
et al., 2012). Although labial salivary gland autograft has less
complication comparing to PDT (Castanho et al., 2013), it still
has the disadvantage of using saliva as a substitute for the
corneal tear film, which could not provide sufficient nutrition,
permits secondary bacterial infection and has adverse effects
on eye surface (Giuliano, 2013). In contrast, using and han-
dling of the adhesives for punctal occlusion have been proved
to be simple and effective with limited complications
(Williams, 2002; Gelatt et al., 2006; Cardoso et al., 2013; Hon-
sho et al., 2014). Additionally, the occlusion of the lower
lacrimal punctum (Williams, 2002) or the upper and lower
puncta (Gelatt et al., 2006) limits tear drainage, provides good
distribution of the pericorneal tear film on the ocular surface,
and prolongs lubrication (Honsho et al., 2014), which resulting
in significant clinical improvement even without increased tear
production (Williams, 2002).
The aim of the present study was to evaluate the efficacy
of the surgical obstruction of the lacrimal puncta versus the
non surgical occlusion using silicone plugs and Butyl-cyano-
acrylate adhesive solution, with the hypothesis that, the most
effective method would provide longer persistency of punctal
occlusion with minimal complications.
Materials and methods
Study design
The study was carried out in two stages as follows: Stage
I, twelve normal, native (balady) dogs, 5 males, 6 females, aged
between one to three years and weighted 16-20 Kg were pur-
chased to be used in this phase. These dogs were subjected
to punctal occlusion and evaluated for sixty days.These ani-
mals were allocated into three equal groups.The punctal oc-
clusion was performed using silicon plugs (group 1, G1),
Butyl-cyanoacrylate adhesive solution (group 2, G2) and sur-
gical method (group 3, G3). Before and after the procedure,
the dogs were examined using indirect ophthalmoscopy,
Jones test,Schirmer tear test I (STTI) and II (STTII). All dogs un-
derwent the first stage of the study haven’t any ocular abnor-
malities, with normal STTI and STTII values and positive to
Jones test. Any ophthalmic or punctal abnormalities were con-
sidered exclusion criteria.
The second stage of this study was carried out on nine
dogs suffering dry eye. These nine cases are 5 males and 4 fe-
males, aged between 8 months to two years and weighted 18-
32 Kg; they were attended to private clinics with
yellowish–greenish exudates accumulated in the conjunctival
sac and ocular hyperemia. To confirm diagnosis of dry-eye,
STT tests were performed and the obtained values were be-
tween 3 and 5 mm/minute. They were treated using the ap-
propriate technique of punctal occlusion that was described
in the first stage. The animals were evaluated for thirty days
after treatment.
All the study procedures and the use of animals were com-
plied with protocols approved by the institutional animal care
committee and adhered to the Egyptian legal requirements.
Stage I (n=12)
Application of STTI and Jones test were done for each dog
before and after carrying out the occlusion technique of the
puncta lacrimalis. The Jones is used for evaluation the patency
of the nasolacrimal drainage system. To achieve that, floures-
cein impregnated paper strips were used. Strips (Optitech eye
care Tarun enterprises, India) were moistened before applica-
tions by one or two drops of sterile saline solution, then
touched the lower conjunctival fornix with moistened tip. The
nostrils were monitored for the appearance of fluorescein. The
results were considered negative (occluded puncta), when the
dye did not appear at nasal opening within 30 to 45 minutes
after application, however considered positive (patent puncta)
if the dye appeared at the nostriles.
STTI was carried out using a standard i.e., maximum read-
ing 35 mm. Sterile STT Strips (Optitech eye care Tarun enter-
prises, India), were placed in the lateral aspect of the lower
fornix for 1 min. Data was measured immediately and
recorded in mm/min, by the same observer.
The animals were fasted 8 hours before anaesthesia. They
were premedicated using 2 mg/kg of xylazine hydrochloride
i/m (Xyla-Ject®, ADWIA CO. S.A.E. Egypt). The animals re-
ceived 10 mg/kg of ketamine hydrochloride i/m (Narketan 10,
Vetoquinol. Co, UK) for general anesthesia. Six out twelve dogs
received half the dose of ketamine hydrochloride at the 60th
minute after starting the procedure for continuation of anes-
thesia.
The animals were in lateral recumbence, the head re-
strained with an assistant and the left eye was prepared anti-
septically using Desomedine® 0.1% eye antiseptic solution
(BAUSH & LOMB incorporated Greenville, U.S.A), whereas the
right eye served as control. The upper and lower conjunctival
fornices were gently dried using a sterile swab. The location
of the upper and lower puncta (Fig. 1) was identified visually
by the aid of loop headband magnifier (Fig. 2) with detachable
light source (MG 81001-B, China), thereafter; the treatment
method was performed as following:
Silicone Plug Punctal Occlusion
In group 1 (G1, n=4), silicon plugs (medical grade silicone
plug, 24 plugs per box, FCI ophthalmics, U.S.A) 0.8 mm in di-
ameter and 2 mm in length was inserted into the upper and
lower puncta (Figs. 3 a,b), with the aid of illumination and
magnification provided by the head-loop. Each plug has a
slightly rounded head and a rod like shaft. To insure that the
plug was inserted correctly, the mucous membrane that cover
the head of the plug should be seen projected externally, in-
dicating successful punctum closure.
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Fig. 1. Location of upper and lower puncta (black arrows) in dog
eye, notice the less pigmented skin around the site of the punctal
orifices, (M) medial canthus, (L) lateral canthus. 
Butyl-cyanoacrylate Punctal Occlusion
In group 2 (G2, n=4), 0.3 ml of butyl-cyanoacrylate solu-
tion (HOPSON®, medical glue 0.5ml/ampule, Ningbo, Hop-
son, China) was injected into the lower and upper puncta,
using sterile 22-24 gauge intravenous catheter (without metal
stylet) (Figs. 4 a,b). First, the catheter introduced slowly into
the puncta until it felt to probe the lacrimal caniliculi, the
catheter stopped when 1-2 mm of its shaft was successfully
inserted, then, 0.3 ml adhesive solution was injected and the
catheter was slowly removed. Successful obstruction was in-
dicated when the hardened adhesive was seen occluding the
puncta. If there was an extra-solution oozed during the pro-
cedure, the operator waited until it hardened and then could
be easily removed by a sterile cotton swab.
Table 1. Statistical data of stage I: STTI values and result of Jones test.
Data expressed as Mean ± SD
*:(according to maximum persistency of punctal occlusion in each technique)
Values with different letter within the same row differed significantly at least at P< 0.05.
Fig. 2. loop headband magnifier with detachable light source.
Fig. 3. (a) Silicon plugs. (b) Inserted silicon plug into lower punc-
tum, notice, pulged mucous membrane indicating succssful inser-
tion. Fig.4. Injection of adhesive solution into the lower (a) and the upper
(b) punctum.
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Surgical method
In group 3 (G3, n=4), the surgical procedure was carried
out using a surgical burr (Fig. 5) of 0.8 mm in diameter to re-
move the epithelium, which line the punctum and the under-
lying lacrimal canaliculi. Subsequently, the stripped surfaces
were sutured together and parallel to the eyelid margin with
a simple interrupted suture pattern using 5/0 polyglycolic acid
(PGA) with 18 mm, ½ circle needle (EGYSORB®, TAISIER-MED,
Egypt).
Surgical occlusion was performed as the following: The
lower punctum was probed using a flexible catheter to facili-
tate entrance of surgical burr (Fig. 6a). The surgical Burr was
introduced into a depth of 2 mm of the lacrimal canaliculi and
gently rotated (Fig. 6b), for removal of lining epithelium that
indicated by oozing of blood and appearance of reddish un-
derlying layers (Fig. 6c). The striped edges were coappetated
together and sutured using simple interrupted suture, parallel
to eyelid margin (Fig. 6d).The same previously described pro-
cedures were repeated for the closure of upper punctum (Fig.
6 e,f,g).
At the end of this stage, left eyes were evaluated using
Jones test and STTI, two times per week, for 60 days, whereas
the STTI values were measured in right eyes as a control. In
addition, the post-operative complications were noticed and
recorded. Data of each animal group was recorded and sta-
tistically analyzed, in order to evaluate the efficacy of each
treatment method. Consequently, the most effective method
required for stage II in this study (clinical cases) was deter-
mined.
Stage II (n=9)
Dry-eye was diagnosed in nine dogs using, clinical signs,
STTI and fluorescent stain as described in Table 2. These nine
cases underwent stage II of this study, and used to apply the
selected method (The surgical method described in stage I).
Prior to surgical interference, these dogs recieved the follow-
ing topical medications: Systane Ultra® (lubricant eye drops
10 ml solution, Alcon Cusl, S.A c/Camil Fabra, Barcelona,
Spain), Olopatadine® 1 mg (Olohistine 5 ml ophthalmic solu-
tion, E.I.P.I.CO.), and Isoptomaxitrol® (antibiotic suspention,
Alcon laboratories, Alcon a Novartis company, USA); 6 times
daily, two drops in each conjunctival sac and for three succes-
sive days. For the first three days after surgery, Polystec-
tran®(antibiotic drops, Alcon laboratories, Alcon a Novartis
company, USA), 2 drops for each eye were used topically in
the conjunctival sac 4 times daily.
Then the surgical method was evaluated again in these
nine cases using the same ophthalmic tests described before
(Jones test and STTI). Data recorded just after the procedure
and twice weekly for 30 days.
Statistical analysis
Data reported in stage I and II were evaluated for normal-
ity using the Shapiro-Wilk test, and the data were determined
to be normally distributed and presented as mean ± SD. Data
of stage I were statistically analyzed by one–way Analysis of
variance (ANOVA) and Duncan's multiple range tests to deter-
mine significant difference between groups with statistical
package for social sciences (SPSS) soft ware (version 17.0). A
value of P< 0.05 was considered significant, as shown in Table
1.
Fig.5. Surgical burr of 0.8 mm in diameter.
Fig. 6. Procedures of surgical punctal occlusion in group 3, subse-
quently represented from (a) to (h): probing the lower punctum (a),
using surgical burr to remove the epithelium (b), lower punctum
after stripping its lining epithelium (c), closure using simple inter-
rupted suture (d), probing the upper punctum (e), removal of ep-
ithelium of upper punctum (f) suturing the stripped upper punctum
(g) left dog eye following procedure, notice the closure does not re-
tract the eye lid margin inward or outward and there is no contact
with corneal surface (h).




Silicone Plug Punctal Occlusion (G1, n=4)
All silicone plugs were easily and successfully inserted. All
the dogs (G1, n=4), tolerate the procedure, no side effects
were noticed. Post procedure evaluation using Jones test was
negative indicated complete occlusion of both puncta for only
20-24 days. Results of STTI values in occluded eyes (19.56±
1.46) were significantly increased than those of control eyes
(17.94 ± 0.60) at P< 0.05 as showen in Table 1, indicating im-
provement of amount of tears forming pericorneal tear film. 
Butyl-cyanoacrylate Punctal Occlusion (G2, n=4)
In group 2, the catheterization of lower and upper puncta
was easily and successful, as the catheter was introduced into
depth of 1-2 mm of lacrimal canaliculi while applying gentle
pressure, no bleeding or injury to mucous membrane was ob-
served (Fig. 4 a,b). No solidification of adhesive solution inside
the catheter was occurred during injection process. Oozing of
adhesive solution was associated with injection of upper punc-
tum more than the lower one, and polymerized particles were
removed safely using cotton swab. 22 gauge catheters were
used in 2 dogs, while 24 gauge catheters were used for the
other 2 dogs. The results of Jones test showed the persistence
of occlusion for 16 days in three dogs and 12 days in the re-
mained one in this group. STTI values (20.31 ± 0.94 ) were sig-
nificantly increased than those of control eyes (17.19± 1.75)
at P< 0.05 as showen in Table 1, but no significant increase
comparing to other methods used in stage I of study. All dogs
were tolerated the procedure and no complications were
recorded. 
Surgical method (G3, n=4)
Surgical occlusion was performed as previously described
(Figs 6 a-g). No entropion or ectropion were observed follow-
ing surgery (Fig. 6h). Evaluation using STTI (Figs. 7 a,b) was in-
dicated significant increase (20.13 ±0.88) comparing to the
control group (17.86 ± 1.65) at P< 0.05, whereas, the results
of Jones test revealing high persistence occlusion for 60 days
as showen in Table 1. There was no significant increase in STTI
values comparing to other groups. A few post operative com-
plications were recorded include, slight local swelling, hyper-
emia around the sutured puncta. These observed
complications disappeared at the end of the third day after
surgery. Complete healing of the sutured puncta was ob-
served at 12-16 days (Fig. 7c).
Stage II (n=9)
The analysis of the data described in stage I indicated that
the surgical method was able to improve the results of STTI
values with longer persistence time (Table 1). The surgical
method was used as an alternative treatment in nine clinical
cases of dry eye. These cases were not responded to several
trails of medical treatments, and the main clinical signs were
include, hyperemia, conjunctivitis, thick yellowish mucopuru-
lent discharges (Figs 8 a,b) chemosis (Fig. 8b) and superficial
keratitis (Figs 8c,d). After preoperative medications and sur-
gery, the cases of 3 mm/min STTI values were slightly im-
proved following surgery and showing higher readings from
6.42 ±0.53 to 8 ± 0.81 mm/min, whereas cases of 4-5 mm/min
were increased to 7.28 ± 0.98 - 9.42 ± 0.53 mm/min (Table 2).
Topical medications were administered for only the first three
days after surgery, and there was no clinical need for continue
medical treatment, as there was no recurrent clinical signs for
30 days of trial. Minor complications include local irritation at
sutured sites were observed in two dogs, but after using neck
collars the dogs become more calm. Local edema was noticed
in 5 dogs and disappeared 48 hours following surgery. Clinical
signs of dry eye were disappeared from 20 – 30 days postop-
eratively (Table 2).
Table 2. Stage II: Animals data, diagnosis and data after using surgical occlusions in 9 clinical cases.
Adel M. Badawy /Journal of Advanced Veterinary Research 7 (4) (2017) 108-115
112
Discussion
Canine dry-eye is a long life and a frequent eye disease in
all visited dogs with reported annual average incidences of 1%
(Dodi, 2015), that requires continuous management, challeng-
ing both the owner and the clinicians. The available topical
medications have the disadvantages of being expensive, fre-
quently administered and a symptomatic treatment extends
throughout the animal life, so, alternative methods are re-
quired (Best et al., 2014). Surgical occlusion of lacrimal puncta
was described in human (Liu and Sadhan, 2002). To the best
of the author knowledge, the present study would be one of
the first studies that provide surgical punctal occlusion in dogs
as an alternative method of refractory cases did not respond
Fig. 7. Post-operative evaluation of eye in group 3, using STTI(a), Jones test (b) and showing complete healing of puncta (black arrows),
at 16 days after surgical occlusion. 
Fig. 8. Eyes of clinically affected dogs with dry-eye that used in stage II of this study: showing, left eye of greyhound (case no. 5) with
dry hyperemic conjunctiva, lose of the luster of the cornea and thick mucopurlent secretion (a) Right eye of German shepherded (case no.
2) with chemosis (swelled, hyperemic conjunctiva) and accumulated white yellowish mucopurulent secretion at medial canthus of eye
(b), fluorescein staining in left eye of German shepherded (case no. 7), indicating superficial keratitis as the dye pooling in the irrigular
surface of the cornea (c, d).
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to medical treatment.
Although other surgical methods, including, parotid duct
transposition (PDT) (Rhodes et al., 2012) and labial salivary
gland autograft (Castanho et al., 2013), are successful meth-
ods, they are not a full replacement for medical treatment, be-
cause a low level of ongoing maintenance is still required
post-operatively (Rhodes et al., 2012). Moreover, the main
principle of these treatments is the use of saliva as a substitute
of precorneal tear film, which may lead to several complica-
tions. In contrast, the surgical technique for punctal occlusion
used in this study, prevented drainage of low amount of pro-
duced tear, as well as it allowed the distribution of tear over
the ocular surface which greatly improve the prognosis and
considered a permanent replacement of medical treatment.
Non-surgical occlusion techniques showen lower perses-
tancy compairing to the surgical technique. This may be due
to the reflex dilatation of the lacrimal canaliculi following ap-
plication of silicon plugs (Williams, 2002) and /or the presence
of moisture inside the canaliculi, as these animals were normal
and the moisture around the polymerized adhesive can pre-
vent intense adhesion between the tissue and the inserted ob-
jects (Rosa et al., 2012), whereas, surgical occlusion, due to the
removal of epithelium of puncta and lacrimal canaliculi may
provide permanent adhesion of tissue, which prevent drainage
of tears in comparison to other techniques of occlusion.
There are different diameters of silicon plug available com-
mercially (0.3- 1 mm). In this study, silicon plugs of diameter
0.8 were beneficial; however, anatomical variations and breeds
should be taken in considerations while repeating this method
in different dogs. Silicon plugs are designed to insert inside
the puncta and the first 1.5 to 2 mm of lacrimal canaliculi
(Williams, 2002), in contrast, the adhesive solution used in the
study can be injected more deeper and has the benefit of tak-
ing the shape of surrounding tissue, in other words, does not
restrict to a particular size as silicon plugs. However, the plugs
used in the study were more stable, and restrained for longer
time (20-24 days) comparing to the polymerized adhesive
which provide occlusion for only 12-16 days. 
There are several types of cyanoacrylate that used for tem-
porary punctal occlusion in dogs, such as ethyl-cyanoacrylate
(Rosa et al., 2012) butyl-cyanoacrylate and octyl-cyanoacrylate
(Honsho et al., 2014). All these types are commercially avail-
able for medical use, but the authors select butyl-cyanoacry-
late for the current study, because its polymerized (hardened)
form has excellent tensile strength and is very effective as ad-
herent for living tissues, additionally it less toxic than the other
forms, in particular, the ethyl products (Ferguson et al., 2003;
Lee et al., 2004). The catheter of 22-24 gauge used in the pres-
ent study was flexible and helpful in injecting both the upper
and lower puncta, while Rosa et al. (2012) used a needle of 25
x 7 mm cut in half to remove the cutting beveled, which was
unable to inject the upper puncta and has problems with ad-
hesive solutions and Honsho et al. (2014) used a 24 gauge
catheter for injecting the lower puncta only.
Although drainage of tear occur mainly through lower
puncta, obstruction of both puncta, is necessary, especially in
cases of low STTI values. As, punctal occlusion does not in-
crease tear production but, maintains produced tears in the
tear lake (Williams, 2002, Gelatt et al., 2006; Cardoso et al.,
2013; Honsho et al., 2014). Obstruction of lower punctum
alone was not successful in clinical cases of low or zero STTI
values (Williams, 2002).
In this study, the surgical method was evaluated in both
normal and clinical dogs. The affected eyes show gradual im-
provement following surgery. Post-operative complications
were limited and sutured edges did not irritate the cornea. For
these, surgical punctal occlusion was successful with minimal
complications, comparing to the high rate of complications
associated with other surgical methods, in particular, PDT, in-
clude, blepharitis, periocular dermatitis intolerance to saliva
and corneal ulceration with associated stromal mineral depo-
sition (Rhodes et al., 2012). In stage II , the maximal recovery
time of the clinical signs was 30 days postoperatively. 
Conclusion
In conclusion, this study described three alternative meth-
ods of treatment of dry-eye in dogs, which are non-surgical
temporary occlusion of puncta using silicon plugs and butyl-
cyanoacrylate adhesive solution and surgical punctal occlu-
sion, which can be used as alternative methods for
unresponsive cases of medical treatment. It proved that the
surgical method was superior to other described methods,
and would be the treatment of choice for severe cases of ca-
nine dry-eye.
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